StockData
Revolution Medicines, Inc. logo

Revolution Medicines, Inc. (RVMD) stock

RVMDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMDW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 3/30
$162.69−4.18 (-2.50%)

Close on Nov 17, 2026Market cap $34.87BP/E –Yield –

Revolution Medicines total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Revolution Medicines

Revolution Medicines has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Revolution Medicines figures

See a number that looks wrong?